How to Apply the Golden Rule of Research to Your Trial Master File

The Golden Rule in clinical research is, “If it’s not written down, it didn’t happen.” Learn how this rule is relevant to being sure your data is credible and the rights and confidentiality of trial subjects are protected.

In this whitepaper, you'll learn:

  • Good Documentation Practice (GDP)
  • How to ensure TMF compliance
  • Guidelines of record keeping and retention
  • How to be inspection-ready
  • Metrics to measure your TMF’s health

  • Download THE

    By supplying my contact information, I authorize ShareVault to contact me about relevant content, products, and services. We're committed to your privacy, for more information, check out our  Privacy Policy .

    WHITEPAPER Contributors:

    Company team

    Sholeh Ehdaivand, Principal Consultant and President

    LMK Clinical Research

    Sholeh is an internationally known TMF Subject Matter Expert with over 15 successful years of experience in the Clinical Research Industry. Her expertise and knowledge in all areas of study management and operational aspects of the clinical trial and document management processes has made her a leader and trusted expert.

    Her experience includes the TMF Reference Model Subject Matter Expert, eTMF management, domestic and international pharmaceutical and biological clinical trials, clinical trial management, site selection, vendor relations, electronic document management, regulatory submissions, quality control processes and implementation and regulatory inspection preparation and participation. Read More

    Company team

    Jackie Morrill, Director of Clinical Operations

    LMK Clinical Research

    Jackie Morrill is a Lean Six Sigma Green Belt certified clinical research professional with nearly a decade of experience in clinical trial coordination and process improvement within the healthcare, biotech, and pharmaceutical industries.

    In recent years, her dedicated focus has been on all things Trial Master File (TMF). Her experience includes oversight of electronic TMF (eTMF) implementation, coordination of a large migration project to move 20+ studies from a paper and/or hybrid TMF to an eTMF, development of a robust metrics and training program, a complete overhaul of TMF QC processes, and extensive inspection readiness preparation for FDA, MHRA, and PDMA inspections. Read More

    Sponsored by: